Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

Clinical trial NCT00065728 · TERMINATED

Trial details

NCT number: NCT00065728
Sponsor: Alcon Research
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 2003-06-01
Primary completion: 2008-10-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.